Affinage

LNPK

Endoplasmic reticulum junction formation protein lunapark · UniProt Q9C0E8

Round 2 corrected
Length
428 aa
Mass
47.7 kDa
Annotated
2026-04-28
130 papers in source corpus 9 papers cited in narrative 9 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

LNPK encodes a conserved, oligomeric ER membrane protein that localizes to three-way junctions of the tubular ER network, where it stabilizes nascent junctions by promoting negative membrane curvature along edge lines and preventing ring closure (PMID:22729086, PMID:25548161, PMID:25404289). LNPK acts antagonistically with the atlastin/Sey1p fusogenic GTPase and reticulon tubule-shaping proteins to balance ER polygonal network architecture; its inactivation by mitotic phosphorylation facilitates the characteristic tubule-to-sheet ER conversion during cell division (PMID:22729086, PMID:27619977). Beyond junction maintenance, LNPK is required for actin-dependent ER remodeling during ER-phagy and cooperates with inner nuclear membrane proteins to preserve the nuclear envelope–ER boundary (PMID:29915089, PMID:32483293). Biallelic loss-of-function mutations in human LNPK cause a recessive neurodevelopmental syndrome featuring intellectual disability, epilepsy, and corpus callosum hypoplasia, with patient cells exhibiting aberrant ER morphology (PMID:30032983).

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 2003 Medium

    Identification of lunapark as a gene sharing limb and CNS regulatory domains with the HoxD cluster established its developmental expression pattern but left its molecular function unknown.

    Evidence Enhancer-trap transgenic reporters and interspecies conservation analysis in mouse

    PMID:12732147

    Open questions at the time
    • No molecular function or subcellular localization determined
    • Regulatory relationship with HoxD genes not mechanistically defined
  2. 2008 Medium

    Loss of the C. elegans ortholog lnp-1 revealed a presynaptic role in synaptic vesicle trafficking, providing the first link between lunapark and membrane compartment organization in neurons.

    Evidence C. elegans deletion mutants with aldicarb/levamisole assays and presynaptic protein mislocalization

    PMID:18279315

    Open questions at the time
    • Mechanism of synaptic vesicle mislocalization not defined at the ER level
    • Relevance to ER morphology not yet recognized
    • Single organism study without mammalian validation
  3. 2012 High

    Discovery that yeast Lnp1p localizes to ER three-way junctions, binds reticulon/Yop1p, and acts antagonistically to the atlastin ortholog Sey1p established the core paradigm: lunapark is an ER junction-stabilizing protein that balances the tubular network against fusogenic forces.

    Evidence Yeast deletion and GTPase-dead mutants, co-immunoprecipitation, fluorescence microscopy of ER morphology

    PMID:22729086

    Open questions at the time
    • Direct curvature-generating or -sensing activity not reconstituted in vitro
    • Mammalian conservation of junction localization not yet confirmed
  4. 2014 High

    Live imaging in mammalian cells and theoretical modeling together showed that Lnp1 stabilizes nascent junctions by promoting negative (S-type) membrane curvature, explaining how it prevents ring closure and maintains ER network geometry.

    Evidence Time-lapse fluorescence imaging of junction mobility and ring closure; mathematical modeling of ER membrane shapes

    PMID:25404289 PMID:25548161

    Open questions at the time
    • Curvature-stabilizing activity inferred from localization and modeling; no in vitro reconstitution with purified protein on liposomes
    • Structural basis for curvature sensing/generation unknown
  5. 2016 High

    Demonstration that Lnp oligomerizes and is inactivated by mitotic phosphorylation linked its biochemical regulation to the cell-cycle-dependent ER tubule-to-sheet conversion, placing Lnp as a regulated effector of ER remodeling during mitosis.

    Evidence Biochemical oligomerization assays, phosphorylation studies during mitosis, manipulation of ATL and Rtn4a levels in mammalian cells

    PMID:27619977

    Open questions at the time
    • Kinase(s) responsible for mitotic phosphorylation not identified
    • Stoichiometry and structural organization of oligomers undetermined
    • How phosphorylation disrupts oligomer function mechanistically unclear
  6. 2018 High

    Two independent advances resolved downstream consequences of Lnp loss: biallelic LNPK mutations were shown to cause a human neurodevelopmental syndrome with aberrant ER in patient cells, while yeast studies demonstrated that Lnp1 is required for ER-phagy by enabling actin-dependent relocalization of the autophagy receptor Atg40.

    Evidence Human exome sequencing and homozygosity mapping across two families with patient cell ER morphology analysis; yeast lnp1Δ mutants with Atg40/Atg11 co-localization and Latrunculin A phenocopy

    PMID:29915089 PMID:30032983

    Open questions at the time
    • Whether ER-phagy defect contributes to the human neurodevelopmental phenotype is untested
    • Direct actin–Lnp1 interaction not demonstrated
    • Mammalian ER-phagy role of LNPK not confirmed
  7. 2020 High

    Genetic studies in fission yeast revealed that Lnp1 cooperates with the inner nuclear membrane protein Lem2 to maintain the NE-ER boundary, expanding lunapark function beyond ER tubule junctions to nuclear envelope integrity.

    Evidence Fission yeast lem2Δ lnp1Δ double mutants with NE/ER morphology analysis and Apq12 genetic suppression

    PMID:32483293

    Open questions at the time
    • Whether NE-ER boundary maintenance function is conserved in mammals
    • Physical interaction between Lnp1 and Lem2 or Apq12 not demonstrated
    • Contribution of NE defects to neurological phenotype in LNPK patients unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key open questions include the atomic structure of LNPK, the identity of kinases controlling its mitotic phosphorylation, whether its ER-phagy and NE-boundary functions operate in mammalian neurons, and how ER junction instability leads to the specific neurodevelopmental deficits seen in patients.
  • No high-resolution structure of LNPK or its oligomeric complex
  • Mammalian in vivo conditional knockout phenotype not reported
  • Pathogenic mechanism linking ER junction loss to corpus callosum hypoplasia and epilepsy undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 4
Localization
GO:0005783 endoplasmic reticulum 6 GO:0005635 nuclear envelope 1
Pathway
R-HSA-1852241 Organelle biogenesis and maintenance 4 R-HSA-1640170 Cell Cycle 1 R-HSA-9612973 Autophagy 1
Partners

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2003 Lunapark (Lnp) was identified as a gene located upstream of the HoxD cluster that shares limb and CNS expression specificities with Hoxd genes and Evx2. Its genomic locus contains a global control region with enhancers capable of directing reporter gene expression in digits and CNS, defining large chromosomal regulatory domains. Targeted enhancer-trap approach, transgenic reporter assays, interspecies sequence conservation analysis Cell Medium 12732147
2008 The C. elegans ortholog lnp-1 is required for synaptic vesicle trafficking and neurotransmission. Deletion mutations in lnp-1 cause resistance to aldicarb (acetylcholinesterase inhibitor) and locomotor defects without affecting sensitivity to the postsynaptic nicotinic agonist levamisole, indicating a presynaptic function. Presynaptic proteins synaptobrevin-1 and RAB-3 are mislocalized in lnp-1 mutants. LNP-1 localization depends on the UNC-104/kinesin motor. C. elegans deletion mutant analysis, aldicarb and levamisole behavioral assays, fluorescence microscopy of presynaptic protein localization, genetic epistasis The European journal of neuroscience Medium 18279315
2012 Yeast Lnp1p localizes to ER tubule three-way junctions and binds to the reticulon protein Rtn1p and Yop1p. Loss of Lnp1p causes a collapsed, densely reticulated ER network. Lnp1p and the dynamin-like GTPase Sey1p (atlastin ortholog) act antagonistically to balance polygonal ER network formation; the lnp1Δ ER collapse is partially restored when Sey1p GTPase activity is abrogated. Yeast genetics (deletion mutants, GTPase-dead mutants), co-immunoprecipitation, fluorescence microscopy of ER morphology, genetic epistasis (double mutants) Nature cell biology High 22729086
2014 Mammalian Lnp1 (mLnp1) localizes to a subset (~50%) of ER three-way junctions. Live-cell imaging shows that junctions containing mLnp1 are less mobile than those without it. Newly formed junctions that acquire mLnp1 remain stable, whereas nascent junctions that fail to acquire mLnp1 undergo rapid ring closure. Thus Lnp1 stabilizes nascent three-way ER junctions and controls network dynamics. Live-cell fluorescence imaging (time-lapse), analysis of junction mobility and ring closure events in mammalian cells Proceedings of the National Academy of Sciences of the United States of America High 25548161
2014 Theoretical and experimental modeling shows that Lunapark is an S-type curvature-stabilizing protein that promotes negative curvature along edge lines, thereby stabilizing three-way junctions (small triangular sheets with concave edges) in the tubular ER network. This distinguishes Lunapark from R-type proteins (reticulons) that favor tubules and outer sheet edges. Mathematical/theoretical modeling of ER morphologies combined with experimental validation of protein localization and membrane curvature effects Proceedings of the National Academy of Sciences of the United States of America Medium 25404289
2016 In higher eukaryotes, Lnp (lunapark) affects the abundance of ER three-way junctions and tubules. Lnp moves into junctional sheets and forms oligomers. Lnp is inactivated by mitotic phosphorylation, which contributes to the tubule-to-sheet conversion of the ER during mitosis. ATL (atlastin) is needed to maintain the ER network and acts by counteracting instability of free tubule ends; Lnp and ATL function in sequence at junctions. Fluorescence microscopy, biochemical analysis of Lnp oligomerization, phosphorylation studies during mitosis, manipulation of ATL and Rtn4a levels eLife High 27619977
2018 Homozygous loss-of-function mutations in human LNPK (encoding lunapark) cause a recessive neurodevelopmental syndrome characterized by severe psychomotor delay, intellectual disability, hypotonia, epilepsy, and corpus callosum hypoplasia. Patient-derived cells lacking full-length lunapark show aberrant ER structures and increased luminal mass density. LNPK is expressed during human and mouse brain development and is present in neurite-like processes of differentiating human neural progenitor cells. Human genetics (homozygosity mapping, exome sequencing), patient cell biology (immunofluorescence, EM of ER morphology), immunohistochemistry and immunofluorescence in human/mouse brain tissue and neural progenitor cells American journal of human genetics High 30032983
2018 Yeast Lnp1 is required for ER-phagy (selective autophagy of the ER) upon rapamycin treatment. Lnp1 normally resides at ER tubule three-way junctions and stabilizes the network during continual remodeling. In lnp1Δ mutants, the ER autophagy receptor Atg40 fails to relocalize to sites of autophagosome formation (marked by the scaffold Atg11), preventing ER packaging into autophagosomes. This block is phenocopied by the actin-depolymerizing drug Latrunculin A, suggesting Lnp1 stabilizes actin-dependent ER remodeling required for ER-phagy. Yeast genetics (lnp1Δ mutants), fluorescence microscopy of Atg40 and Atg11 co-localization, pharmacological actin depolymerization, rapamycin-induced autophagy assays Proceedings of the National Academy of Sciences of the United States of America High 29915089
2020 In fission yeast, Lnp1 and the inner nuclear membrane protein Lem2 cooperatively maintain the membrane boundary between the nuclear envelope (NE) and endoplasmic reticulum (ER). Cells lacking both Lem2 and Lnp1 show severe growth defects, aberrant NE/ER membrane expansion, leakage of nuclear proteins, and abnormal vacuolar-like structures in the nucleus. Overexpression of the ER membrane protein Apq12 rescues the growth defect, and genetic analysis shows Apq12 has overlapping functions with Lnp1. Fission yeast genetics (double deletion mutants lem2Δ lnp1Δ), fluorescence microscopy of NE/ER morphology and nuclear protein localization, genetic suppressor analysis (Apq12 overexpression) Communications biology High 32483293

Source papers

Stage 0 corpus · 130 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2861 17081983
2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 1479 12477932
2015 The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell 1118 26186194
2017 Architecture of the human interactome defines protein communities and disease networks. Nature 1085 28514442
2015 A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 1015 26496610
2020 A reference map of the human binary protein interactome. Nature 849 32296183
2003 Complete sequencing and characterization of 21,243 full-length human cDNAs. Nature genetics 754 14702039
2007 Large-scale mapping of human protein-protein interactions by mass spectrometry. Molecular systems biology 733 17353931
2021 Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 705 33961781
2011 Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Briefings in bioinformatics 656 21873635
2018 High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies. Molecular cell 580 29395067
2004 The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome research 438 15489334
2015 A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface. Cell 433 26638075
2005 Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome research 409 16344560
2003 A global control region defines a chromosomal regulatory landscape containing the HoxD cluster. Cell 375 12732147
2021 A proximity-dependent biotinylation map of a human cell. Nature 339 34079125
2023 Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy. Advanced materials (Deerfield Beach, Fla.) 330 37196221
2024 Endosomal escape: A bottleneck for LNP-mediated therapeutics. Proceedings of the National Academy of Sciences of the United States of America 325 38437552
2012 Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 319 22810586
2019 Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nature communications 315 31551417
2012 Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PloS one 312 23251661
2021 Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. Nature communications 229 34880218
2016 An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. Nature communications 211 27173435
2022 Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects. Journal of nanobiotechnology 168 35701851
2019 A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nature immunology 159 30833792
2020 The effects of PEGylation on LNP based mRNA delivery to the eye. PloS one 152 33119640
2016 Cooperation of the ER-shaping proteins atlastin, lunapark, and reticulons to generate a tubular membrane network. eLife 150 27619977
2023 Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability. NPJ vaccines 148 37821446
2020 A High-Density Human Mitochondrial Proximity Interaction Network. Cell metabolism 148 32877691
2009 Ubiquitin-mediated proteolysis of HuR by heat shock. The EMBO journal 142 19322201
2012 ER network formation requires a balance of the dynamin-like GTPase Sey1p and the Lunapark family member Lnp1p. Nature cell biology 126 22729086
2024 AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nature communications 119 39060305
2012 Genome-wide association study of periodontal pathogen colonization. Journal of dental research 110 22699663
2023 Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Science translational medicine 106 36867683
2016 Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. Cell 105 27716508
2014 Lunapark stabilizes nascent three-way junctions in the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 105 25548161
2014 A model for the generation and interconversion of ER morphologies. Proceedings of the National Academy of Sciences of the United States of America 101 25404289
2022 mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells. Molecular therapy : the journal of the American Society of Gene Therapy 98 35821637
1997 Ulnaless (Ul), a regulatory mutation inducing both loss-of-function and gain-of-function of posterior Hoxd genes. Development (Cambridge, England) 98 9342042
2017 The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion. Oncogene 96 28692057
2022 Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. Journal of controlled release : official journal of the Controlled Release Society 94 35640764
2017 R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein. Nature communications 94 28561026
2023 Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma. Angewandte Chemie (International ed. in English) 92 37651468
2021 Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 89 34343897
2019 Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines. ACS infectious diseases 88 31290323
2023 Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. Communications biology 86 36805684
2021 Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety. Biomedicines 81 34068715
2021 A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses. Journal of virology 79 33762420
2023 A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science advances 73 36888708
2022 Optimal self-assembly of lipid nanoparticles (LNP) in a ring micromixer. Scientific reports 64 35676394
2023 Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection. Science advances 63 37738334
2024 A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection. Science (New York, N.Y.) 62 39361752
1996 The UL 16 gene product of herpes simplex virus 1 is a virion protein that colocalizes with intranuclear capsid proteins. Virology 62 8955043
2019 Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy. Molecular therapy. Nucleic acids 61 31877409
2023 STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2. Nano letters 59 36942873
2024 mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies. Science (New York, N.Y.) 58 38753770
2024 Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy. Nature communications 58 39122711
2023 Esterase-Labile Quaternium Lipidoid Enabling Improved mRNA-LNP Stability and Spleen-Selective mRNA Transfection. Advanced materials (Deerfield Beach, Fla.) 54 37490011
2022 Lipid Nanoparticle (LNP) Chemistry Can Endow Unique In Vivo RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model. Molecular pharmaceutics 52 36154076
2024 Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy. Journal of controlled release : official journal of the Controlled Release Society 48 38876358
2018 ER-phagy requires Lnp1, a protein that stabilizes rearrangements of the ER network. Proceedings of the National Academy of Sciences of the United States of America 46 29915089
2024 LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing. Nature communications 45 38272900
2024 Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart. Proceedings of the National Academy of Sciences of the United States of America 45 38437539
2001 Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity. Journal of medicinal chemistry 44 11334568
2023 Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids. Biomaterials science 43 37073472
2023 mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer. NPJ vaccines 43 37773254
2022 mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum. NPJ vaccines 42 36456563
1996 Gene organization in the UL region and inverted repeats of the canine herpesvirus genome. The Journal of general virology 42 8558127
2024 Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies. Research (Washington, D.C.) 37 38894715
2024 Quality assessment of LNP-RNA therapeutics with orthogonal analytical techniques. Journal of controlled release : official journal of the Controlled Release Society 36 38253203
2025 Investigating the stability of RNA-lipid nanoparticles in biological fluids: Unveiling its crucial role for understanding LNP performance. Journal of controlled release : official journal of the Controlled Release Society 35 40023226
2024 Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings. Journal of controlled release : official journal of the Controlled Release Society 35 39059500
2023 VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis. Cell stem cell 33 38029740
1992 Blockade of the pacemaker current by intracellular application of UL-FS 49 and UL-AH 99 in sheep cardiac Purkinje fibers. European journal of pharmacology 30 1473563
2024 Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria. Journal of controlled release : official journal of the Controlled Release Society 29 38697317
2020 Lem2 and Lnp1 maintain the membrane boundary between the nuclear envelope and endoplasmic reticulum. Communications biology 28 32483293
2018 Mutations in LNPK, Encoding the Endoplasmic Reticulum Junction Stabilizer Lunapark, Cause a Recessive Neurodevelopmental Syndrome. American journal of human genetics 27 30032983
2024 mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions. International journal of molecular sciences 25 38612407
2023 Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA-LNP-Based Vaccines. Vaccines 25 37515040
1996 The BamHI fragment 9 of pseudorabies virus contains genes homologous to the UL24, UL25, UL26, and UL 26.5 genes of herpes simplex virus type 1. Virus research 25 8806172
2025 An Il12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses. Science immunology 24 40478935
2024 mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models. Science immunology 24 38753808
2022 Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses. PLoS pathogens 24 35073387
2023 mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth. Cancers 23 37345198
2023 A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1. Viruses 23 37515169
2022 Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants. Pharmaceutics 23 35631687
2024 Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines. Journal of biomedical science 22 38233833
2023 Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 21 37579889
2023 Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model. Molecular therapy. Nucleic acids 21 38028196
2023 Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines. International journal of pharmaceutics 21 38081560
1998 Analysis of human herpesvirus 6 U3 gene, which is a positional homolog of human cytomegalovirus UL 24 gene. Virology 21 9740784
2025 Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence. Journal of nanobiotechnology 20 39844298
2022 A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice. Virologica Sinica 20 35835315
2022 Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques. Frontiers in immunology 20 35935984
2022 An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization. International journal of pharmaceutics 20 36198358
2024 Impact of mixing and shaking on mRNA-LNP drug product quality characteristics. Scientific reports 19 39179645
2022 Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species. Cell reports 19 35921835
2024 Preformed Vesicle Approach to LNP Manufacturing Enhances Retinal mRNA Delivery. Small (Weinheim an der Bergstrasse, Germany) 18 38738752
2024 Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nature communications 17 38987276
2014 Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92. Journal of virology 17 24899204
2023 Targeting Ligand Independent Tropism of siRNA-LNP by Small Molecules for Directed Therapy of Liver or Myeloid Immune Cells. Advanced healthcare materials 16 36617516
2022 Protective Immune Responses Induced by an mRNA-LNP Vaccine Encoding prM-E Proteins against Japanese Encephalitis Virus Infection. Viruses 16 35746593
2022 Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study. Vaccine: X 16 35791320
2025 Overview on LNP-mRNA encapsulation unit operation: Mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics. International journal of pharmaceutics 15 39900125
2025 LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment. Nature communications 15 40038251
2024 Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer. Small (Weinheim an der Bergstrasse, Germany) 15 38829038
2024 Synergistic integration of mRNA-LNP with CAR-engineered immune cells: Pioneering progress in immunotherapy. Molecular therapy : the journal of the American Society of Gene Therapy 15 39295145
2024 Characterization of mRNA-LNP structural features and mechanisms for enhanced mRNA vaccine immunogenicity. Journal of controlled release : official journal of the Controlled Release Society 15 39522562
2014 The regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients. Scientific reports 15 25138242
2024 Correlating Stability-Indicating Biochemical and Biophysical Characteristics with In Vitro Cell Potency in mRNA LNP Vaccine. Vaccines 14 38400152
2024 Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Molecular therapy. Nucleic acids 14 38576454
2023 A novel Toxoplasma gondii TGGT1_316290 mRNA-LNP vaccine elicits protective immune response against toxoplasmosis in mice. Frontiers in microbiology 14 37025641
2023 Immunization with a novel mRNA vaccine, TGGT1_216200 mRNA-LNP, prolongs survival time in BALB/c mice against acute toxoplasmosis. Frontiers in immunology 14 37122740
2017 Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents. Virology 14 28711653
2008 Non-photochemical loss in PSII in high- and low-light-grown leaves of Vicia faba quantified by several fluorescence parameters including L(NP), F0/F'm, a novel parameter. Physiologia plantarum 14 18346081
2024 Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine. NPJ vaccines 13 38575581
2024 LNP-mRNA vaccine prevents type 1 diabetes in non-obese diabetes mice. Journal of controlled release : official journal of the Controlled Release Society 13 39278354
2024 Efficient and safe in vivo treatment of primary hyperoxaluria type 1 via LNP-CRISPR-Cas9-mediated glycolate oxidase disruption. Molecular therapy : the journal of the American Society of Gene Therapy 13 39385468
2021 Impact of Ribosome Activity on SARS-CoV-2 LNP - Based mRNA Vaccines. Frontiers in molecular biosciences 11 33959636
2008 The evolutionarily conserved gene LNP-1 is required for synaptic vesicle trafficking and synaptic transmission. The European journal of neuroscience 11 18279315
2025 An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis. EBioMedicine 10 39955975
2025 Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases. Journal of controlled release : official journal of the Controlled Release Society 10 40120689
2025 The design, manufacture and LNP formulation of mRNA for research use. Nature protocols 10 40494942
2024 In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia. Molecular diagnosis & therapy 10 38538969
2024 Analytical Ultracentrifugation to Assess the Quality of LNP-mRNA Therapeutics. International journal of molecular sciences 10 38891903
2022 Z-Guggulsterone Is a Potential Lead Molecule of Dawa-ul-Kurkum against Hepatocellular Carcinoma. Molecules (Basel, Switzerland) 10 36014345
2019 A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study). PloS one 10 31560700
2025 From in vitro to in vivo: The Dominant role of PEG-Lipids in LNP performance. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 9 40286880
2024 Safety, Immunogenicity, and Mechanism of a Rotavirus mRNA-LNP Vaccine in Mice. Viruses 9 38399987
2022 Single-cell suspension preparation from murine organs following in vivo mRNA-LNP exposure. STAR protocols 8 35620070